Table of Content

1 Insomnia Medication Market Overview
1.1 Product Overview and Scope of Insomnia Medication
1.2 Insomnia Medication Segment by Type
1.2.1 Global Insomnia Medication Market Value Comparison by Type (2024-2034)
1.2.2 Nonbenzodiazepine Receptor Agonists
1.2.3 Benzodiazepine Receptor Agonists
1.2.4 The Selective Melatonin Receptor Agonist Ramelteon
1.2.5 Sedating Antidepressants
1.3 Insomnia Medication Segment by Application
1.3.1 Global Insomnia Medication Market Value by Application: (2024-2034)
1.3.2 Adults
1.3.3 Kids
1.4 Global Insomnia Medication Market Size Estimates and Forecasts
1.4.1 Global Insomnia Medication Revenue 2018-2034
1.4.2 Global Insomnia Medication Sales 2018-2034
1.4.3 Global Insomnia Medication Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Insomnia Medication Market Competition by Manufacturers
2.1 Global Insomnia Medication Sales Market Share by Manufacturers (2018-2023)
2.2 Global Insomnia Medication Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Insomnia Medication Average Price by Manufacturers (2018-2023)
2.4 Global Insomnia Medication Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Insomnia Medication, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Insomnia Medication, Product Type & Application
2.7 Insomnia Medication Market Competitive Situation and Trends
2.7.1 Insomnia Medication Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Insomnia Medication Players Market Share by Revenue
2.7.3 Global Insomnia Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Insomnia Medication Retrospective Market Scenario by Region
3.1 Global Insomnia Medication Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Insomnia Medication Global Insomnia Medication Sales by Region: 2018-2034
3.2.1 Global Insomnia Medication Sales by Region: 2018-2023
3.2.2 Global Insomnia Medication Sales by Region: 2024-2034
3.3 Global Insomnia Medication Global Insomnia Medication Revenue by Region: 2018-2034
3.3.1 Global Insomnia Medication Revenue by Region: 2018-2023
3.3.2 Global Insomnia Medication Revenue by Region: 2024-2034
3.4 North America Insomnia Medication Market Facts & Figures by Country
3.4.1 North America Insomnia Medication Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Insomnia Medication Sales by Country (2018-2034)
3.4.3 North America Insomnia Medication Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Insomnia Medication Market Facts & Figures by Country
3.5.1 Europe Insomnia Medication Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Insomnia Medication Sales by Country (2018-2034)
3.5.3 Europe Insomnia Medication Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Insomnia Medication Market Facts & Figures by Country
3.6.1 Asia Pacific Insomnia Medication Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Insomnia Medication Sales by Country (2018-2034)
3.6.3 Asia Pacific Insomnia Medication Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Insomnia Medication Market Facts & Figures by Country
3.7.1 Latin America Insomnia Medication Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Insomnia Medication Sales by Country (2018-2034)
3.7.3 Latin America Insomnia Medication Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Insomnia Medication Market Facts & Figures by Country
3.8.1 Middle East and Africa Insomnia Medication Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Insomnia Medication Sales by Country (2018-2034)
3.8.3 Middle East and Africa Insomnia Medication Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Insomnia Medication Sales by Type (2018-2034)
4.1.1 Global Insomnia Medication Sales by Type (2018-2023)
4.1.2 Global Insomnia Medication Sales by Type (2024-2034)
4.1.3 Global Insomnia Medication Sales Market Share by Type (2018-2034)
4.2 Global Insomnia Medication Revenue by Type (2018-2034)
4.2.1 Global Insomnia Medication Revenue by Type (2018-2023)
4.2.2 Global Insomnia Medication Revenue by Type (2024-2034)
4.2.3 Global Insomnia Medication Revenue Market Share by Type (2018-2034)
4.3 Global Insomnia Medication Price by Type (2018-2034)
5 Segment by Application
5.1 Global Insomnia Medication Sales by Application (2018-2034)
5.1.1 Global Insomnia Medication Sales by Application (2018-2023)
5.1.2 Global Insomnia Medication Sales by Application (2024-2034)
5.1.3 Global Insomnia Medication Sales Market Share by Application (2018-2034)
5.2 Global Insomnia Medication Revenue by Application (2018-2034)
5.2.1 Global Insomnia Medication Revenue by Application (2018-2023)
5.2.2 Global Insomnia Medication Revenue by Application (2024-2034)
5.2.3 Global Insomnia Medication Revenue Market Share by Application (2018-2034)
5.3 Global Insomnia Medication Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Eisai
6.1.1 Eisai Corporation Information
6.1.2 Eisai Description and Business Overview
6.1.3 Eisai Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Eisai Insomnia Medication Product Portfolio
6.1.5 Eisai Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Merck Insomnia Medication Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Pfizer Insomnia Medication Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Sanofi
6.4.1 Sanofi Corporation Information
6.4.2 Sanofi Description and Business Overview
6.4.3 Sanofi Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi Insomnia Medication Product Portfolio
6.4.5 Sanofi Recent Developments/Updates
6.5 Takeda
6.5.1 Takeda Corporation Information
6.5.2 Takeda Description and Business Overview
6.5.3 Takeda Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Takeda Insomnia Medication Product Portfolio
6.5.5 Takeda Recent Developments/Updates
6.6 Vanda Pharmaceuticals
6.6.1 Vanda Pharmaceuticals Corporation Information
6.6.2 Vanda Pharmaceuticals Description and Business Overview
6.6.3 Vanda Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Vanda Pharmaceuticals Insomnia Medication Product Portfolio
6.6.5 Vanda Pharmaceuticals Recent Developments/Updates
6.7 Astellas
6.6.1 Astellas Corporation Information
6.6.2 Astellas Description and Business Overview
6.6.3 Astellas Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Astellas Insomnia Medication Product Portfolio
6.7.5 Astellas Recent Developments/Updates
6.8 Dainippon Sumitomo
6.8.1 Dainippon Sumitomo Corporation Information
6.8.2 Dainippon Sumitomo Description and Business Overview
6.8.3 Dainippon Sumitomo Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Dainippon Sumitomo Insomnia Medication Product Portfolio
6.8.5 Dainippon Sumitomo Recent Developments/Updates
6.9 ECR Pharmaceuticals (Valeant)
6.9.1 ECR Pharmaceuticals (Valeant) Corporation Information
6.9.2 ECR Pharmaceuticals (Valeant) Description and Business Overview
6.9.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.9.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Product Portfolio
6.9.5 ECR Pharmaceuticals (Valeant) Recent Developments/Updates
6.10 Flynn Pharma
6.10.1 Flynn Pharma Corporation Information
6.10.2 Flynn Pharma Description and Business Overview
6.10.3 Flynn Pharma Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Flynn Pharma Insomnia Medication Product Portfolio
6.10.5 Flynn Pharma Recent Developments/Updates
6.11 Johnson & Johnson
6.11.1 Johnson & Johnson Corporation Information
6.11.2 Johnson & Johnson Insomnia Medication Description and Business Overview
6.11.3 Johnson & Johnson Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Johnson & Johnson Insomnia Medication Product Portfolio
6.11.5 Johnson & Johnson Recent Developments/Updates
6.12 Meda
6.12.1 Meda Corporation Information
6.12.2 Meda Insomnia Medication Description and Business Overview
6.12.3 Meda Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Meda Insomnia Medication Product Portfolio
6.12.5 Meda Recent Developments/Updates
6.13 Somnus Therapeutics
6.13.1 Somnus Therapeutics Corporation Information
6.13.2 Somnus Therapeutics Insomnia Medication Description and Business Overview
6.13.3 Somnus Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Somnus Therapeutics Insomnia Medication Product Portfolio
6.13.5 Somnus Therapeutics Recent Developments/Updates
6.14 Purdue Pharma
6.14.1 Purdue Pharma Corporation Information
6.14.2 Purdue Pharma Insomnia Medication Description and Business Overview
6.14.3 Purdue Pharma Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Purdue Pharma Insomnia Medication Product Portfolio
6.14.5 Purdue Pharma Recent Developments/Updates
6.15 Neurim
6.15.1 Neurim Corporation Information
6.15.2 Neurim Insomnia Medication Description and Business Overview
6.15.3 Neurim Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Neurim Insomnia Medication Product Portfolio
6.15.5 Neurim Recent Developments/Updates
6.16 Minerva Neurosciences
6.16.1 Minerva Neurosciences Corporation Information
6.16.2 Minerva Neurosciences Insomnia Medication Description and Business Overview
6.16.3 Minerva Neurosciences Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Minerva Neurosciences Insomnia Medication Product Portfolio
6.16.5 Minerva Neurosciences Recent Developments/Updates
6.17 Pernix Therapeutics
6.17.1 Pernix Therapeutics Corporation Information
6.17.2 Pernix Therapeutics Insomnia Medication Description and Business Overview
6.17.3 Pernix Therapeutics Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Pernix Therapeutics Insomnia Medication Product Portfolio
6.17.5 Pernix Therapeutics Recent Developments/Updates
6.18 SkyePharma
6.18.1 SkyePharma Corporation Information
6.18.2 SkyePharma Insomnia Medication Description and Business Overview
6.18.3 SkyePharma Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.18.4 SkyePharma Insomnia Medication Product Portfolio
6.18.5 SkyePharma Recent Developments/Updates
6.19 Paratek Pharmaceuticals
6.19.1 Paratek Pharmaceuticals Corporation Information
6.19.2 Paratek Pharmaceuticals Insomnia Medication Description and Business Overview
6.19.3 Paratek Pharmaceuticals Insomnia Medication Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Paratek Pharmaceuticals Insomnia Medication Product Portfolio
6.19.5 Paratek Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Insomnia Medication Industry Chain Analysis
7.2 Insomnia Medication Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Insomnia Medication Production Mode & Process
7.4 Insomnia Medication Sales and Marketing
7.4.1 Insomnia Medication Sales Channels
7.4.2 Insomnia Medication Distributors
7.5 Insomnia Medication Customers
8 Insomnia Medication Market Dynamics
8.1 Insomnia Medication Industry Trends
8.2 Insomnia Medication Market Drivers
8.3 Insomnia Medication Market Challenges
8.4 Insomnia Medication Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Insomnia Medication Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Insomnia Medication Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Insomnia Medication Market Competitive Situation by Manufacturers in 2024
Table 4. Global Insomnia Medication Sales (K Pcs) of Key Manufacturers (2018-2023)
Table 5. Global Insomnia Medication Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Insomnia Medication Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Insomnia Medication Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Insomnia Medication Average Price (USD/Pcs) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Insomnia Medication, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Insomnia Medication, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Insomnia Medication, Product Type & Application
Table 12. Global Key Manufacturers of Insomnia Medication, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Insomnia Medication by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Insomnia Medication as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Insomnia Medication Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Insomnia Medication Sales by Region (2018-2023) & (K Pcs)
Table 18. Global Insomnia Medication Sales Market Share by Region (2018-2023)
Table 19. Global Insomnia Medication Sales by Region (2024-2034) & (K Pcs)
Table 20. Global Insomnia Medication Sales Market Share by Region (2024-2034)
Table 21. Global Insomnia Medication Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Insomnia Medication Revenue Market Share by Region (2018-2023)
Table 23. Global Insomnia Medication Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Insomnia Medication Revenue Market Share by Region (2024-2034)
Table 25. North America Insomnia Medication Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Insomnia Medication Sales by Country (2018-2023) & (K Pcs)
Table 27. North America Insomnia Medication Sales by Country (2024-2034) & (K Pcs)
Table 28. North America Insomnia Medication Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Insomnia Medication Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Insomnia Medication Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Insomnia Medication Sales by Country (2018-2023) & (K Pcs)
Table 32. Europe Insomnia Medication Sales by Country (2024-2034) & (K Pcs)
Table 33. Europe Insomnia Medication Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Insomnia Medication Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Insomnia Medication Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Insomnia Medication Sales by Region (2018-2023) & (K Pcs)
Table 37. Asia Pacific Insomnia Medication Sales by Region (2024-2034) & (K Pcs)
Table 38. Asia Pacific Insomnia Medication Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Insomnia Medication Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Insomnia Medication Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Insomnia Medication Sales by Country (2018-2023) & (K Pcs)
Table 42. Latin America Insomnia Medication Sales by Country (2024-2034) & (K Pcs)
Table 43. Latin America Insomnia Medication Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Insomnia Medication Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Insomnia Medication Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Insomnia Medication Sales by Country (2018-2023) & (K Pcs)
Table 47. Middle East & Africa Insomnia Medication Sales by Country (2024-2034) & (K Pcs)
Table 48. Middle East & Africa Insomnia Medication Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Insomnia Medication Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Insomnia Medication Sales (K Pcs) by Type (2018-2023)
Table 51. Global Insomnia Medication Sales (K Pcs) by Type (2024-2034)
Table 52. Global Insomnia Medication Sales Market Share by Type (2018-2023)
Table 53. Global Insomnia Medication Sales Market Share by Type (2024-2034)
Table 54. Global Insomnia Medication Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Insomnia Medication Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Insomnia Medication Revenue Market Share by Type (2018-2023)
Table 57. Global Insomnia Medication Revenue Market Share by Type (2024-2034)
Table 58. Global Insomnia Medication Price (USD/Pcs) by Type (2018-2023)
Table 59. Global Insomnia Medication Price (USD/Pcs) by Type (2024-2034)
Table 60. Global Insomnia Medication Sales (K Pcs) by Application (2018-2023)
Table 61. Global Insomnia Medication Sales (K Pcs) by Application (2024-2034)
Table 62. Global Insomnia Medication Sales Market Share by Application (2018-2023)
Table 63. Global Insomnia Medication Sales Market Share by Application (2024-2034)
Table 64. Global Insomnia Medication Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Insomnia Medication Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Insomnia Medication Revenue Market Share by Application (2018-2023)
Table 67. Global Insomnia Medication Revenue Market Share by Application (2024-2034)
Table 68. Global Insomnia Medication Price (USD/Pcs) by Application (2018-2023)
Table 69. Global Insomnia Medication Price (USD/Pcs) by Application (2024-2034)
Table 70. Eisai Corporation Information
Table 71. Eisai Description and Business Overview
Table 72. Eisai Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 73. Eisai Insomnia Medication Product
Table 74. Eisai Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 78. Merck Insomnia Medication Product
Table 79. Merck Recent Developments/Updates
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 83. Pfizer Insomnia Medication Product
Table 84. Pfizer Recent Developments/Updates
Table 85. Sanofi Corporation Information
Table 86. Sanofi Description and Business Overview
Table 87. Sanofi Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 88. Sanofi Insomnia Medication Product
Table 89. Sanofi Recent Developments/Updates
Table 90. Takeda Corporation Information
Table 91. Takeda Description and Business Overview
Table 92. Takeda Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 93. Takeda Insomnia Medication Product
Table 94. Takeda Recent Developments/Updates
Table 95. Vanda Pharmaceuticals Corporation Information
Table 96. Vanda Pharmaceuticals Description and Business Overview
Table 97. Vanda Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 98. Vanda Pharmaceuticals Insomnia Medication Product
Table 99. Vanda Pharmaceuticals Recent Developments/Updates
Table 100. Astellas Corporation Information
Table 101. Astellas Description and Business Overview
Table 102. Astellas Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 103. Astellas Insomnia Medication Product
Table 104. Astellas Recent Developments/Updates
Table 105. Dainippon Sumitomo Corporation Information
Table 106. Dainippon Sumitomo Description and Business Overview
Table 107. Dainippon Sumitomo Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 108. Dainippon Sumitomo Insomnia Medication Product
Table 109. Dainippon Sumitomo Recent Developments/Updates
Table 110. ECR Pharmaceuticals (Valeant) Corporation Information
Table 111. ECR Pharmaceuticals (Valeant) Description and Business Overview
Table 112. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 113. ECR Pharmaceuticals (Valeant) Insomnia Medication Product
Table 114. ECR Pharmaceuticals (Valeant) Recent Developments/Updates
Table 115. Flynn Pharma Corporation Information
Table 116. Flynn Pharma Description and Business Overview
Table 117. Flynn Pharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 118. Flynn Pharma Insomnia Medication Product
Table 119. Flynn Pharma Recent Developments/Updates
Table 120. Johnson & Johnson Corporation Information
Table 121. Johnson & Johnson Description and Business Overview
Table 122. Johnson & Johnson Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 123. Johnson & Johnson Insomnia Medication Product
Table 124. Johnson & Johnson Recent Developments/Updates
Table 125. Meda Corporation Information
Table 126. Meda Description and Business Overview
Table 127. Meda Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 128. Meda Insomnia Medication Product
Table 129. Meda Recent Developments/Updates
Table 130. Somnus Therapeutics Corporation Information
Table 131. Somnus Therapeutics Description and Business Overview
Table 132. Somnus Therapeutics Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 133. Somnus Therapeutics Insomnia Medication Product
Table 134. Somnus Therapeutics Recent Developments/Updates
Table 135. Purdue Pharma Corporation Information
Table 136. Purdue Pharma Description and Business Overview
Table 137. Purdue Pharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 138. Purdue Pharma Insomnia Medication Product
Table 139. Purdue Pharma Recent Developments/Updates
Table 140. Neurim Corporation Information
Table 141. Neurim Description and Business Overview
Table 142. Neurim Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 143. Neurim Insomnia Medication Product
Table 144. Neurim Recent Developments/Updates
Table 145. Minerva Neurosciences Corporation Information
Table 146. Minerva Neurosciences Description and Business Overview
Table 147. Minerva Neurosciences Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 148. Minerva Neurosciences Insomnia Medication Product
Table 149. Minerva Neurosciences Recent Developments/Updates
Table 150. Pernix Therapeutics Corporation Information
Table 151. Pernix Therapeutics Description and Business Overview
Table 152. Pernix Therapeutics Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 153. Pernix Therapeutics Insomnia Medication Product
Table 154. Pernix Therapeutics Recent Developments/Updates
Table 155. SkyePharma Corporation Information
Table 156. SkyePharma Description and Business Overview
Table 157. SkyePharma Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 158. SkyePharma Insomnia Medication Product
Table 159. SkyePharma Recent Developments/Updates
Table 160. Paratek Pharmaceuticals Corporation Information
Table 161. Paratek Pharmaceuticals Description and Business Overview
Table 162. Paratek Pharmaceuticals Insomnia Medication Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 163. Paratek Pharmaceuticals Insomnia Medication Product
Table 164. Paratek Pharmaceuticals Recent Developments/Updates
Table 165. Key Raw Materials Lists
Table 166. Raw Materials Key Suppliers Lists
Table 167. Insomnia Medication Distributors List
Table 168. Insomnia Medication Customers List
Table 169. Insomnia Medication Market Trends
Table 170. Insomnia Medication Market Drivers
Table 171. Insomnia Medication Market Challenges
Table 172. Insomnia Medication Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Insomnia Medication
Figure 2. Global Insomnia Medication Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Insomnia Medication Market Share by Type in 2024 & 2034
Figure 4. Nonbenzodiazepine Receptor Agonists Product Picture
Figure 5. Benzodiazepine Receptor Agonists Product Picture
Figure 6. The Selective Melatonin Receptor Agonist Ramelteon Product Picture
Figure 7. Sedating Antidepressants Product Picture
Figure 8. Global Insomnia Medication Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Insomnia Medication Market Share by Application in 2024 & 2034
Figure 10. Adults
Figure 11. Kids
Figure 12. Global Insomnia Medication Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Insomnia Medication Market Size (2018-2034) & (US$ Million)
Figure 14. Global Insomnia Medication Sales (2018-2034) & (K Pcs)
Figure 15. Global Insomnia Medication Average Price (USD/Pcs) & (2018-2034)
Figure 16. Insomnia Medication Report Years Considered
Figure 17. Insomnia Medication Sales Share by Manufacturers in 2024
Figure 18. Global Insomnia Medication Revenue Share by Manufacturers in 2024
Figure 19. The Global 5 and 10 Largest Insomnia Medication Players: Market Share by Revenue in 2024
Figure 20. Insomnia Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 21. Global Insomnia Medication Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 22. North America Insomnia Medication Sales Market Share by Country (2018-2034)
Figure 23. North America Insomnia Medication Revenue Market Share by Country (2018-2034)
Figure 24. U.S. Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Canada Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Europe Insomnia Medication Sales Market Share by Country (2018-2034)
Figure 27. Europe Insomnia Medication Revenue Market Share by Country (2018-2034)
Figure 28. Germany Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. France Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. U.K. Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Italy Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Russia Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Asia Pacific Insomnia Medication Sales Market Share by Region (2018-2034)
Figure 34. Asia Pacific Insomnia Medication Revenue Market Share by Region (2018-2034)
Figure 35. China Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Japan Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. South Korea Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. India Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Australia Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. China Taiwan Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Indonesia Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Thailand Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Malaysia Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Insomnia Medication Sales Market Share by Country (2018-2034)
Figure 45. Latin America Insomnia Medication Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Insomnia Medication Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Insomnia Medication Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. UAE Insomnia Medication Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Insomnia Medication by Type (2018-2034)
Figure 55. Global Revenue Market Share of Insomnia Medication by Type (2018-2034)
Figure 56. Global Insomnia Medication Price (USD/Pcs) by Type (2018-2034)
Figure 57. Global Sales Market Share of Insomnia Medication by Application (2018-2034)
Figure 58. Global Revenue Market Share of Insomnia Medication by Application (2018-2034)
Figure 59. Global Insomnia Medication Price (USD/Pcs) by Application (2018-2034)
Figure 60. Insomnia Medication Value Chain
Figure 61. Insomnia Medication Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed